Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Avidity Biosciences Inc (NQ: RNA )

46.95 +5.08 (+12.13%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 9, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,487,268
Open 47.37
Bid (Size) 46.92 (1)
Ask (Size) 47.34 (15)
Prev. Close 41.87
Today's Range 43.01 - 47.50
52wk Range 4.825 - 48.80
Shares Outstanding 54,462,518
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
RNA Stock Earnings: Avidity Biosciences Beats EPS, Misses Revenue for Q2 2024
RNA stock results show that Avidity Biosciences beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Expedia Posts Upbeat Earnings, Joins Akamai Technologies, Trade Desk, DXC Technology And Other Big Stocks Moving Higher On Friday
Via Benzinga

Performance

YTD
+412.55%
+412.55%
1 Month
+4.80%
+4.80%
3 Month
+80.44%
+80.44%
6 Month
+222.90%
+222.90%
1 Year
+435.35%
+435.35%

More News

Read More
How Avidity Biosciences Just Dropped The Hammer On Sarepta Therapeutics
Via Investor's Business Daily
3 Stocks Doing Even Better Than Superstar Super Micro (SMCI)
Via InvestorPlace
3 Russell 2000 Growth Stocks That Could Be Worth the Risk
Via The Motley Fool
Topics Economy
Exposures Interest Rates
(RNA) - Analyzing Avidity Biosciences's Short Interest
Via Benzinga
Chart Of The Day: Avidity Biosciences - Something's Up?
Via Talk Markets
A Glimpse Into The Expert Outlook On Avidity Biosciences Through 6 Analysts
Via Benzinga
GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testing
Via Benzinga
Top Performing Industry ETFs In June: Software Leads Returns, Chipmakers Attract Most Inflows
Via Benzinga
Topics ETFs
Trading SMID Biotech Stocks In A Volatile Market
Via Talk Markets
Navigating 7 Analyst Ratings For Avidity Biosciences
Via Benzinga
Avidity Biosciences And CleanSpark Were Among The 10 Biggest Mid-Cap Stock Gainers Last Week (June 9-June 15): Are These In Your Portfolio?
Via Benzinga
Adobe, Avidity Biosciences And 3 Stocks To Watch Heading Into Friday
Via Benzinga
Crude Oil Moves Higher; Vera Bradley Shares Slide
Via Benzinga
Exposures Fossil Fuels
Why Streamline Health Solutions Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Nasdaq Jumps 300 Points; Oracle Shares Spike Higher
Via Benzinga
Why Avidity Biosciences Shares Are Trading Higher Wednesday
Via Benzinga
Casey's Reports Upbeat Earnings, Joins Avidity Biosciences, Rentokil Initial And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
The 'Impressive' Results That Sent Top 1% Avidity Biosciences To A High Point
Via Investor's Business Daily
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
2 Potentially High-Reward Growth Stocks to Buy Right Now
Via The Motley Fool
Dip Then Rip? 3 Nasdaq Stocks to Buy Before the Rebound
Via InvestorPlace
RNA Stock Earnings: Avidity Biosciences Misses EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.